PERCEPTIVE ADVISORS LLC

Holdings History for BRIGHT MINDS BIOSCIENCES INC. - Common Stock (DRUG)

Symbol: DRUG on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 449,290 shares
Security Ownership %: 4.6%

Shares, Excluding Options vs Price

Value, Excluding Options

Perceptive Advisors LLC ownership in BRIGHT MINDS BIOSCIENCES INC. Common Stock (DRUG)

17 Feb 2026 - Perceptive Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 449,290 shares of BRIGHT MINDS BIOSCIENCES INC. Common Stock (DRUG). This represents 4.6% ownership of the company. In their previous filing dated 15 May 2025, PERCEPTIVE ADVISORS LLC had reported owning 444,649 shares, indicating an increase of +1%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Perceptive Advisors LLC	4.6%	-28%	$40,171,019	449,290	+4,641	+1%	$89.41	13G/A	31 Dec 2025	17 Feb 2026, 16:00
Perceptive Advisors LLC	6.3%		$13,735,208	444,649			$30.89	13G/A	31 Mar 2025	15 May 2025, 16:30

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.64%	0%	$35,062,592	449,290	0		$78.04	Q4 2025
30 Sep 2025	0.8%	+0.05%	$27,253,931	449,290	+28,600	+6.8%	$60.66	Q3 2025
30 Jun 2025	0.41%	-0.02%	$10,984,216	420,690	-23,959	-5.4%	$26.11	Q2 2025
31 Mar 2025	0.57%	+0.05%	$16,038,489	444,649	+41,000	+10%	$36.07	Q1 2025
31 Dec 2024	0.41%	+0.41%	$14,539,437	403,649	+403,649	NEW	$36.02	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.